Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Radiosensitivity Analysis in Pediatric Oncology (FOCUSO)
NCT06033183Recruiting
- Sponsor
- Neolys Pharma
- Start
- Dec 2023
- Primary completion
- Aug 2027
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by Neolys Pharma. Primary endpoint: Discriminating capacities of the RadioDtect individual radiosensitivity blood test on the occurrence of early radio-induced toxicities at 24 months. Started Dec 2023; status: recruiting.
Beyond the preview
Go deeper on NCT06033183.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06033183.